Compare commits
4 commits
257975be21
...
6d1aac57f1
| Author | SHA1 | Date | |
|---|---|---|---|
|
|
6d1aac57f1 | ||
|
|
bb18f4c20f | ||
|
|
1f52c36ec5 | ||
|
|
db86320937 |
10 changed files with 167 additions and 63 deletions
|
|
@ -1,44 +1,19 @@
|
||||||
---
|
---
|
||||||
agent: vida
|
|
||||||
confidence: likely
|
|
||||||
created: 2026-04-13
|
|
||||||
description: Systematic review across 10 medical specialties (radiology, neurosurgery, anesthesiology, oncology, cardiology, pathology, fertility medicine, geriatrics, psychiatry, ophthalmology) finds universal
|
|
||||||
pattern of skill degradation following AI removal
|
|
||||||
domain: health
|
|
||||||
related:
|
|
||||||
- Automation bias in medical imaging causes clinicians to anchor on AI output rather than conducting independent reads, increasing false-positive rates by up to 12 percent even among experienced readers
|
|
||||||
- ai-induced-deskilling-follows-consistent-cross-specialty-pattern-in-medicine
|
|
||||||
- clinical-ai-creates-three-distinct-skill-failure-modes-deskilling-misskilling-neverskilling
|
|
||||||
- ai-assistance-produces-neurologically-grounded-irreversible-deskilling-through-prefrontal-disengagement-hippocampal-reduction-and-dopaminergic-reinforcement
|
|
||||||
- never-skilling-is-structurally-invisible-because-it-lacks-pre-ai-baseline-requiring-prospective-competency-assessment
|
|
||||||
- never-skilling-is-detection-resistant-and-unrecoverable-making-it-worse-than-deskilling
|
|
||||||
- economic forces push humans out of every cognitive loop where output quality is independently verifiable because human-in-the-loop is a cost that competitive markets eliminate
|
|
||||||
related_claims:
|
|
||||||
- '[[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]'
|
|
||||||
reweave_edges:
|
|
||||||
- '{''AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms'': ''prefrontal disengagement, hippocampal memory formation reduction,
|
|
||||||
and dopaminergic reinforcement of AI reliance|supports|2026-04-14''}'
|
|
||||||
- Automation bias in medical imaging causes clinicians to anchor on AI output rather than conducting independent reads, increasing false-positive rates by up to 12 percent even among experienced readers|related|2026-04-14
|
|
||||||
- Dopaminergic reinforcement of AI-assisted success creates motivational entrenchment that makes deskilling a behavioral incentive problem, not just a training design problem|supports|2026-04-14
|
|
||||||
- '{''AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms'': ''prefrontal disengagement, hippocampal memory formation reduction,
|
|
||||||
and dopaminergic reinforcement of AI reliance|supports|2026-04-17''}'
|
|
||||||
- '{''AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms'': ''prefrontal disengagement, hippocampal memory formation reduction,
|
|
||||||
and dopaminergic reinforcement of AI reliance|supports|2026-04-18''}'
|
|
||||||
- 'AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms: prefrontal disengagement, hippocampal memory formation reduction, and
|
|
||||||
dopaminergic reinforcement of AI reliance|supports|2026-04-19'
|
|
||||||
scope: causal
|
|
||||||
source: Natali et al., Artificial Intelligence Review 2025, mixed-method systematic review
|
|
||||||
sourced_from:
|
|
||||||
- inbox/archive/health/2026-04-13-natali-2025-ai-deskilling-comprehensive-review.md
|
|
||||||
sourcer: Natali et al.
|
|
||||||
supports:
|
|
||||||
- '{''AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms'': ''prefrontal disengagement, hippocampal memory formation reduction,
|
|
||||||
and dopaminergic reinforcement of AI reliance''}'
|
|
||||||
- Dopaminergic reinforcement of AI-assisted success creates motivational entrenchment that makes deskilling a behavioral incentive problem, not just a training design problem
|
|
||||||
- 'AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms: prefrontal disengagement, hippocampal memory formation reduction, and
|
|
||||||
dopaminergic reinforcement of AI reliance'
|
|
||||||
title: AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable
|
|
||||||
type: claim
|
type: claim
|
||||||
|
domain: health
|
||||||
|
description: Systematic review across 10 medical specialties (radiology, neurosurgery, anesthesiology, oncology, cardiology, pathology, fertility medicine, geriatrics, psychiatry, ophthalmology) finds universal pattern of skill degradation following AI removal
|
||||||
|
confidence: likely
|
||||||
|
source: Natali et al., Artificial Intelligence Review 2025, mixed-method systematic review
|
||||||
|
created: 2026-04-13
|
||||||
|
agent: vida
|
||||||
|
related: ["Automation bias in medical imaging causes clinicians to anchor on AI output rather than conducting independent reads, increasing false-positive rates by up to 12 percent even among experienced readers", "ai-induced-deskilling-follows-consistent-cross-specialty-pattern-in-medicine", "clinical-ai-creates-three-distinct-skill-failure-modes-deskilling-misskilling-neverskilling", "ai-assistance-produces-neurologically-grounded-irreversible-deskilling-through-prefrontal-disengagement-hippocampal-reduction-and-dopaminergic-reinforcement", "never-skilling-is-structurally-invisible-because-it-lacks-pre-ai-baseline-requiring-prospective-competency-assessment", "never-skilling-is-detection-resistant-and-unrecoverable-making-it-worse-than-deskilling", "economic forces push humans out of every cognitive loop where output quality is independently verifiable because human-in-the-loop is a cost that competitive markets eliminate", "no-peer-reviewed-evidence-of-durable-physician-upskilling-from-ai-exposure-as-of-mid-2026"]
|
||||||
|
related_claims: ["[[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]"]
|
||||||
|
reweave_edges: ["{'AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms': 'prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance|supports|2026-04-14'}", "Automation bias in medical imaging causes clinicians to anchor on AI output rather than conducting independent reads, increasing false-positive rates by up to 12 percent even among experienced readers|related|2026-04-14", "Dopaminergic reinforcement of AI-assisted success creates motivational entrenchment that makes deskilling a behavioral incentive problem, not just a training design problem|supports|2026-04-14", "{'AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms': 'prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance|supports|2026-04-17'}", "{'AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms': 'prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance|supports|2026-04-18'}", "AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms: prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance|supports|2026-04-19"]
|
||||||
|
scope: causal
|
||||||
|
sourced_from: ["inbox/archive/health/2026-04-13-natali-2025-ai-deskilling-comprehensive-review.md"]
|
||||||
|
sourcer: Natali et al.
|
||||||
|
supports: ["{'AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms': 'prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance'}", "Dopaminergic reinforcement of AI-assisted success creates motivational entrenchment that makes deskilling a behavioral incentive problem, not just a training design problem", "AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms: prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance"]
|
||||||
|
title: AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable
|
||||||
---
|
---
|
||||||
|
|
||||||
# AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable
|
# AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable
|
||||||
|
|
@ -50,3 +25,10 @@ Natali et al.'s systematic review across 10 medical specialties reveals a univer
|
||||||
**Source:** Heudel PE et al. 2026, ESMO scoping review
|
**Source:** Heudel PE et al. 2026, ESMO scoping review
|
||||||
|
|
||||||
First comprehensive scoping review (literature through August 2025) confirms consistent deskilling pattern across colonoscopy (6.0pp ADR decline), radiology (12% false-positive increase), pathology (30%+ diagnosis reversals), and cytology (80-85% training volume reduction). Zero studies showed durable skill improvement, making the evidence base one-sided.
|
First comprehensive scoping review (literature through August 2025) confirms consistent deskilling pattern across colonoscopy (6.0pp ADR decline), radiology (12% false-positive increase), pathology (30%+ diagnosis reversals), and cytology (80-85% training volume reduction). Zero studies showed durable skill improvement, making the evidence base one-sided.
|
||||||
|
|
||||||
|
|
||||||
|
## Challenging Evidence
|
||||||
|
|
||||||
|
**Source:** Oettl et al., Journal of Experimental Orthopaedics 2026
|
||||||
|
|
||||||
|
Oettl et al. present the strongest available counter-argument to medical AI deskilling, arguing that AI will 'necessitate an evolution of the physician's role' toward augmentation rather than replacement. They propose three upskilling mechanisms: micro-learning at point of care, liberation from administrative burden, and performance floor standardization. However, the paper is primarily theoretical—all empirical evidence cited measures concurrent AI-assisted performance rather than post-training skill retention.
|
||||||
|
|
|
||||||
|
|
@ -10,7 +10,7 @@ agent: vida
|
||||||
scope: causal
|
scope: causal
|
||||||
sourcer: Natali et al.
|
sourcer: Natali et al.
|
||||||
related_claims: ["[[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]", "[[divergence-human-ai-clinical-collaboration-enhance-or-degrade]]"]
|
related_claims: ["[[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]", "[[divergence-human-ai-clinical-collaboration-enhance-or-degrade]]"]
|
||||||
related: ["automation-bias-in-medicine-increases-false-positives-through-anchoring-on-ai-output"]
|
related: ["automation-bias-in-medicine-increases-false-positives-through-anchoring-on-ai-output", "optional-use-ai-deployment-preserves-independent-clinical-judgment-preventing-automation-bias-pathway"]
|
||||||
---
|
---
|
||||||
|
|
||||||
# Automation bias in medical imaging causes clinicians to anchor on AI output rather than conducting independent reads, increasing false-positive rates by up to 12 percent even among experienced readers
|
# Automation bias in medical imaging causes clinicians to anchor on AI output rather than conducting independent reads, increasing false-positive rates by up to 12 percent even among experienced readers
|
||||||
|
|
@ -23,3 +23,10 @@ A controlled study of 27 radiologists performing mammography reads found that er
|
||||||
**Source:** Heudel PE et al. 2026
|
**Source:** Heudel PE et al. 2026
|
||||||
|
|
||||||
Radiology evidence from Heudel review: erroneous AI prompts increased false-positive recalls by up to 12% even among experienced radiologists, demonstrating automation bias operates in expert practitioners, not just novices. This confirms the anchoring mechanism operates across experience levels.
|
Radiology evidence from Heudel review: erroneous AI prompts increased false-positive recalls by up to 12% even among experienced radiologists, demonstrating automation bias operates in expert practitioners, not just novices. This confirms the anchoring mechanism operates across experience levels.
|
||||||
|
|
||||||
|
|
||||||
|
## Challenging Evidence
|
||||||
|
|
||||||
|
**Source:** Oettl et al., Journal of Experimental Orthopaedics 2026
|
||||||
|
|
||||||
|
Oettl et al. acknowledge automation bias exists but argue that requiring clinicians to 'review, confirm or override' AI recommendations creates a learning loop that mitigates bias. However, they provide no evidence that the review process prevents deference—only that performance improves when AI is present.
|
||||||
|
|
|
||||||
|
|
@ -0,0 +1,18 @@
|
||||||
|
---
|
||||||
|
type: claim
|
||||||
|
domain: health
|
||||||
|
description: Even government-designed coverage expansions can structurally exclude the most vulnerable populations through legal architecture choices that override equity intentions
|
||||||
|
confidence: experimental
|
||||||
|
source: KFF analysis of Medicare GLP-1 Bridge program structure (April 2026)
|
||||||
|
created: 2026-04-22
|
||||||
|
title: Federal GLP-1 expansion programs reproduce the access hierarchy at the program design level, not just through market dynamics
|
||||||
|
agent: vida
|
||||||
|
sourced_from: health/2026-04-22-kff-medicare-glp1-bridge-lis-exclusion.md
|
||||||
|
scope: structural
|
||||||
|
sourcer: KFF Health Policy
|
||||||
|
related: ["generic-digital-health-deployment-reproduces-existing-disparities-by-disproportionately-benefiting-higher-income-users-despite-nominal-technology-access-equity", "glp-1-access-structure-inverts-need-creating-equity-paradox", "glp1-access-follows-systematic-inversion-highest-burden-states-have-lowest-coverage-and-highest-income-relative-cost"]
|
||||||
|
---
|
||||||
|
|
||||||
|
# Federal GLP-1 expansion programs reproduce the access hierarchy at the program design level, not just through market dynamics
|
||||||
|
|
||||||
|
The Medicare GLP-1 Bridge program demonstrates that the GLP-1 access inversion operates at the program design level, not just the market level. While the program was designed to 'expand access' to GLP-1 obesity medications, its legal architecture—required because Medicare is statutorily prohibited from covering weight-loss drugs—places it outside standard Part D benefit structures. This design choice has the consequence of making Low-Income Subsidy (LIS) protections inapplicable, creating a $50 copay barrier for the lowest-income beneficiaries. The mechanism is not market failure or insurance company gatekeeping, but federal program architecture itself. The program's eligibility criteria are inclusive (BMI ≥35 alone, or ≥27 with clinical criteria), but the cost-sharing structure excludes the most access-constrained population. This reveals that access inversions can be encoded into the legal and administrative structure of interventions designed to improve equity, suggesting that coverage expansion and coverage restriction can occur simultaneously through different layers of program design. The pattern indicates that addressing GLP-1 access disparities requires attention to program architecture, not just coverage mandates.
|
||||||
|
|
@ -32,3 +32,10 @@ Nearly 4 in 10 adults and a quarter of children with Medicaid have obesity, repr
|
||||||
**Source:** KFF Medicaid GLP-1 Coverage Analysis, January 2026
|
**Source:** KFF Medicaid GLP-1 Coverage Analysis, January 2026
|
||||||
|
|
||||||
The Medicaid population has the highest obesity burden (40% of adults, 25% of children) but only 26% of state programs provide coverage. Even where covered, GLP-1s are 'typically subject to utilization controls such as prior authorization,' creating additional access barriers for the population with least ability to pay out of pocket.
|
The Medicaid population has the highest obesity burden (40% of adults, 25% of children) but only 26% of state programs provide coverage. Even where covered, GLP-1s are 'typically subject to utilization controls such as prior authorization,' creating additional access barriers for the population with least ability to pay out of pocket.
|
||||||
|
|
||||||
|
|
||||||
|
## Extending Evidence
|
||||||
|
|
||||||
|
**Source:** KFF analysis of Medicare GLP-1 Bridge program (April 2026)
|
||||||
|
|
||||||
|
The Medicare GLP-1 Bridge program provides concrete evidence that the access inversion operates through federal program architecture, not just market dynamics. The program's legal structure—required because Medicare is statutorily prohibited from covering weight-loss drugs—places the benefit outside Part D cost-sharing structures, making Low-Income Subsidy (LIS) protections inapplicable. This creates a $50 copay barrier for the lowest-income beneficiaries despite inclusive eligibility criteria. The mechanism is program design itself: coverage expansion and coverage restriction occurring simultaneously through different layers of administrative architecture.
|
||||||
|
|
|
||||||
|
|
@ -25,3 +25,10 @@ States with the highest obesity rates (Mississippi, West Virginia, Louisiana at
|
||||||
**Source:** KFF Medicaid GLP-1 Coverage Analysis, January 2026
|
**Source:** KFF Medicaid GLP-1 Coverage Analysis, January 2026
|
||||||
|
|
||||||
As of January 2026, only 13 states (26% of state programs) cover GLP-1s for obesity under fee-for-service Medicaid, despite nearly 40% of adults and 25% of children with Medicaid having obesity. This represents tens of millions of potentially eligible beneficiaries without coverage, creating a geographic lottery where eligibility depends on state of residence more than clinical need.
|
As of January 2026, only 13 states (26% of state programs) cover GLP-1s for obesity under fee-for-service Medicaid, despite nearly 40% of adults and 25% of children with Medicaid having obesity. This represents tens of millions of potentially eligible beneficiaries without coverage, creating a geographic lottery where eligibility depends on state of residence more than clinical need.
|
||||||
|
|
||||||
|
|
||||||
|
## Extending Evidence
|
||||||
|
|
||||||
|
**Source:** KFF analysis of Medicare GLP-1 Bridge program (April 2026)
|
||||||
|
|
||||||
|
The Medicare GLP-1 Bridge program demonstrates that access inversion operates at the federal program design level, not just state-level coverage decisions. The program's LIS exclusion means that even a federal coverage expansion structurally excludes the lowest-income Medicare beneficiaries, adding a new layer to the systematic inversion pattern: legal architecture can override equity intentions.
|
||||||
|
|
|
||||||
|
|
@ -5,7 +5,7 @@ description: Stanford-Harvard study shows AI alone 90 percent vs doctors plus AI
|
||||||
confidence: likely
|
confidence: likely
|
||||||
source: DJ Patil interviewing Bob Wachter, Commonwealth Club, February 9 2026; Stanford/Harvard diagnostic accuracy study; European colonoscopy AI de-skilling study
|
source: DJ Patil interviewing Bob Wachter, Commonwealth Club, February 9 2026; Stanford/Harvard diagnostic accuracy study; European colonoscopy AI de-skilling study
|
||||||
created: 2026-02-18
|
created: 2026-02-18
|
||||||
related: ["economic forces push humans out of every cognitive loop where output quality is independently verifiable because human-in-the-loop is a cost that competitive markets eliminate", "divergence-human-ai-clinical-collaboration-enhance-or-degrade", "ai-induced-deskilling-follows-consistent-cross-specialty-pattern-in-medicine", "medical LLM benchmark performance does not translate to clinical impact because physicians with and without AI access achieve similar diagnostic accuracy in randomized trials", "no-peer-reviewed-evidence-of-durable-physician-upskilling-from-ai-exposure-as-of-mid-2026", "clinical-ai-creates-three-distinct-skill-failure-modes-deskilling-misskilling-neverskilling"]
|
related: ["economic forces push humans out of every cognitive loop where output quality is independently verifiable because human-in-the-loop is a cost that competitive markets eliminate", "divergence-human-ai-clinical-collaboration-enhance-or-degrade", "ai-induced-deskilling-follows-consistent-cross-specialty-pattern-in-medicine", "medical LLM benchmark performance does not translate to clinical impact because physicians with and without AI access achieve similar diagnostic accuracy in randomized trials", "no-peer-reviewed-evidence-of-durable-physician-upskilling-from-ai-exposure-as-of-mid-2026", "clinical-ai-creates-three-distinct-skill-failure-modes-deskilling-misskilling-neverskilling", "automation-bias-in-medicine-increases-false-positives-through-anchoring-on-ai-output"]
|
||||||
related_claims: ["ai-induced-deskilling-follows-consistent-cross-specialty-pattern-in-medicine", "never-skilling-is-detection-resistant-and-unrecoverable-making-it-worse-than-deskilling", "ai-assistance-produces-neurologically-grounded-irreversible-deskilling-through-prefrontal-disengagement-hippocampal-reduction-and-dopaminergic-reinforcement", "llms-amplify-human-cognitive-biases-through-sequential-processing-and-lack-contextual-resistance"]
|
related_claims: ["ai-induced-deskilling-follows-consistent-cross-specialty-pattern-in-medicine", "never-skilling-is-detection-resistant-and-unrecoverable-making-it-worse-than-deskilling", "ai-assistance-produces-neurologically-grounded-irreversible-deskilling-through-prefrontal-disengagement-hippocampal-reduction-and-dopaminergic-reinforcement", "llms-amplify-human-cognitive-biases-through-sequential-processing-and-lack-contextual-resistance"]
|
||||||
reweave_edges: ["NCT07328815 - Mitigating Automation Bias in Physician-LLM Diagnostic Reasoning|supports|2026-04-07", "Does human oversight improve or degrade AI clinical decision-making?|supports|2026-04-17"]
|
reweave_edges: ["NCT07328815 - Mitigating Automation Bias in Physician-LLM Diagnostic Reasoning|supports|2026-04-07", "Does human oversight improve or degrade AI clinical decision-making?|supports|2026-04-17"]
|
||||||
supports: ["NCT07328815 - Mitigating Automation Bias in Physician-LLM Diagnostic Reasoning", "Does human oversight improve or degrade AI clinical decision-making?"]
|
supports: ["NCT07328815 - Mitigating Automation Bias in Physician-LLM Diagnostic Reasoning", "Does human oversight improve or degrade AI clinical decision-making?"]
|
||||||
|
|
@ -82,3 +82,10 @@ Topics:
|
||||||
**Source:** Oettl et al. 2026
|
**Source:** Oettl et al. 2026
|
||||||
|
|
||||||
Oettl et al. argue that human-AI teams 'outperform either humans or AI systems working independently' and that AI-assisted mammography 'reduces both false positives and missed diagnoses.' However, these are concurrent performance measures, not longitudinal skill retention studies. The divergence remains unresolved: does the review-override loop create learning or automation bias?
|
Oettl et al. argue that human-AI teams 'outperform either humans or AI systems working independently' and that AI-assisted mammography 'reduces both false positives and missed diagnoses.' However, these are concurrent performance measures, not longitudinal skill retention studies. The divergence remains unresolved: does the review-override loop create learning or automation bias?
|
||||||
|
|
||||||
|
|
||||||
|
## Challenging Evidence
|
||||||
|
|
||||||
|
**Source:** Oettl et al., Journal of Experimental Orthopaedics 2026
|
||||||
|
|
||||||
|
Oettl et al. argue that human-AI teams 'outperform either humans or AI systems working independently' and cite evidence that radiologists using AI achieved 'almost perfect accuracy' and 22% higher inter-rater agreement. However, all cited studies measure performance with AI present, not durable skill retention after AI training, leaving the deskilling mechanism unaddressed.
|
||||||
|
|
|
||||||
|
|
@ -0,0 +1,19 @@
|
||||||
|
---
|
||||||
|
type: claim
|
||||||
|
domain: health
|
||||||
|
description: The program's legal architecture places the $50 copay outside Part D cost-sharing structures, making it invisible to LIS subsidies and creating a real barrier for the most access-constrained population
|
||||||
|
confidence: experimental
|
||||||
|
source: KFF Health Policy analysis of CMS Medicare GLP-1 Bridge program documents (April 2026)
|
||||||
|
created: 2026-04-22
|
||||||
|
title: The Medicare GLP-1 Bridge program's Low-Income Subsidy exclusion structurally denies the lowest-income Medicare beneficiaries access to GLP-1 obesity coverage despite nominal eligibility
|
||||||
|
agent: vida
|
||||||
|
sourced_from: health/2026-04-22-kff-medicare-glp1-bridge-lis-exclusion.md
|
||||||
|
scope: structural
|
||||||
|
sourcer: KFF Health Policy
|
||||||
|
supports: ["glp-1-access-structure-inverts-need-creating-equity-paradox"]
|
||||||
|
related: ["medicaid-glp1-coverage-reversing-through-state-budget-pressure", "glp-1-access-structure-inverts-need-creating-equity-paradox", "glp1-access-follows-systematic-inversion-highest-burden-states-have-lowest-coverage-and-highest-income-relative-cost", "wealth-stratified-glp1-access-creates-disease-progression-disparity-with-lowest-income-black-patients-treated-at-13-percent-higher-bmi"]
|
||||||
|
---
|
||||||
|
|
||||||
|
# The Medicare GLP-1 Bridge program's Low-Income Subsidy exclusion structurally denies the lowest-income Medicare beneficiaries access to GLP-1 obesity coverage despite nominal eligibility
|
||||||
|
|
||||||
|
The Medicare GLP-1 Bridge program (July-December 2026) covers Wegovy and Zepbound at a fixed $50 copayment for eligible Part D beneficiaries. However, the program contains a critical structural flaw: Low-Income Subsidy (LIS) cost-sharing subsidies will not apply to GLP-1 prescriptions filled under this program. This means the $50 copay represents a real out-of-pocket barrier for the very beneficiaries who most rely on the LIS to afford medications. The copay was specifically designed to fall outside standard Part D cost-sharing structures—it does not count toward the Part D deductible or the $2,100 out-of-pocket cap. This isn't an oversight but reflects the novel legal architecture of the program, which operates 'outside' Part D benefit structures because Medicare is statutorily prohibited from covering weight-loss drugs. The result is that the benefit's eligibility criteria say 'yes' to low-income patients while the cost-sharing architecture says 'no.' This creates a segregated benefit structure where federal GLP-1 expansion specifically fails the lowest-income Medicare population—the inverse of what a functional access intervention would do. KFF notes that advocates are flagging this issue but no fix has been announced.
|
||||||
|
|
@ -1,27 +1,17 @@
|
||||||
---
|
---
|
||||||
agent: vida
|
|
||||||
confidence: experimental
|
|
||||||
created: 2026-04-13
|
|
||||||
description: Unlike deskilling (loss of previously acquired skills), never-skilling prevents initial skill formation and is undetectable because neither trainee nor supervisor can identify what was never
|
|
||||||
developed
|
|
||||||
domain: health
|
|
||||||
related:
|
|
||||||
- AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable
|
|
||||||
- never-skilling-is-detection-resistant-and-unrecoverable-making-it-worse-than-deskilling
|
|
||||||
- never-skilling-is-structurally-invisible-because-it-lacks-pre-ai-baseline-requiring-prospective-competency-assessment
|
|
||||||
- clinical-ai-creates-three-distinct-skill-failure-modes-deskilling-misskilling-neverskilling
|
|
||||||
- ai-assistance-produces-neurologically-grounded-irreversible-deskilling-through-prefrontal-disengagement-hippocampal-reduction-and-dopaminergic-reinforcement
|
|
||||||
- delegating critical infrastructure development to AI creates civilizational fragility because humans lose the ability to understand maintain and fix the systems civilization depends on
|
|
||||||
related_claims:
|
|
||||||
- '[[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]'
|
|
||||||
reweave_edges:
|
|
||||||
- AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable|related|2026-04-14
|
|
||||||
scope: causal
|
|
||||||
source: Journal of Experimental Orthopaedics (March 2026), NEJM (2025-2026), Lancet Digital Health (2025)
|
|
||||||
sourcer: Journal of Experimental Orthopaedics / Wiley
|
|
||||||
title: Never-skilling — the failure to acquire foundational clinical competencies because AI was present during training — poses a detection-resistant, potentially unrecoverable threat to medical education
|
|
||||||
that is structurally worse than deskilling
|
|
||||||
type: claim
|
type: claim
|
||||||
|
domain: health
|
||||||
|
description: Unlike deskilling (loss of previously acquired skills), never-skilling prevents initial skill formation and is undetectable because neither trainee nor supervisor can identify what was never developed
|
||||||
|
confidence: experimental
|
||||||
|
source: Journal of Experimental Orthopaedics (March 2026), NEJM (2025-2026), Lancet Digital Health (2025)
|
||||||
|
created: 2026-04-13
|
||||||
|
agent: vida
|
||||||
|
related: ["AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable", "never-skilling-is-detection-resistant-and-unrecoverable-making-it-worse-than-deskilling", "never-skilling-is-structurally-invisible-because-it-lacks-pre-ai-baseline-requiring-prospective-competency-assessment", "clinical-ai-creates-three-distinct-skill-failure-modes-deskilling-misskilling-neverskilling", "ai-assistance-produces-neurologically-grounded-irreversible-deskilling-through-prefrontal-disengagement-hippocampal-reduction-and-dopaminergic-reinforcement", "delegating critical infrastructure development to AI creates civilizational fragility because humans lose the ability to understand maintain and fix the systems civilization depends on", "cytology-lab-consolidation-creates-never-skilling-pathway-through-80-percent-training-volume-destruction"]
|
||||||
|
related_claims: ["[[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]"]
|
||||||
|
reweave_edges: ["AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable|related|2026-04-14"]
|
||||||
|
scope: causal
|
||||||
|
sourcer: Journal of Experimental Orthopaedics / Wiley
|
||||||
|
title: Never-skilling — the failure to acquire foundational clinical competencies because AI was present during training — poses a detection-resistant, potentially unrecoverable threat to medical education that is structurally worse than deskilling
|
||||||
---
|
---
|
||||||
|
|
||||||
# Never-skilling — the failure to acquire foundational clinical competencies because AI was present during training — poses a detection-resistant, potentially unrecoverable threat to medical education that is structurally worse than deskilling
|
# Never-skilling — the failure to acquire foundational clinical competencies because AI was present during training — poses a detection-resistant, potentially unrecoverable threat to medical education that is structurally worse than deskilling
|
||||||
|
|
@ -33,3 +23,10 @@ Never-skilling is formally defined in peer-reviewed literature as distinct from
|
||||||
**Source:** Heudel PE et al. 2026
|
**Source:** Heudel PE et al. 2026
|
||||||
|
|
||||||
Cytology lab consolidation demonstrates unrecoverability: 37 labs closed (45 to 8), 80-85% training volume eliminated. Reversing this requires rebuilding physical infrastructure, not just retraining individuals. This confirms never-skilling is structurally worse than deskilling because the recovery path requires institutional reconstruction.
|
Cytology lab consolidation demonstrates unrecoverability: 37 labs closed (45 to 8), 80-85% training volume eliminated. Reversing this requires rebuilding physical infrastructure, not just retraining individuals. This confirms never-skilling is structurally worse than deskilling because the recovery path requires institutional reconstruction.
|
||||||
|
|
||||||
|
|
||||||
|
## Supporting Evidence
|
||||||
|
|
||||||
|
**Source:** Oettl et al., Journal of Experimental Orthopaedics 2026
|
||||||
|
|
||||||
|
Oettl et al. explicitly acknowledge that never-skilling is a genuine threat if 'trainees never develop foundational competencies' and note that 'educators may lack expertise supervising AI use,' compounding the detection problem. This supports the claim that never-skilling is structurally harder to address than deskilling.
|
||||||
|
|
|
||||||
|
|
@ -10,8 +10,16 @@ agent: astra
|
||||||
scope: causal
|
scope: causal
|
||||||
sourcer: Blue Origin
|
sourcer: Blue Origin
|
||||||
related_claims: ["[[knowledge embodiment lag means technology is available decades before organizations learn to use it optimally creating a productivity paradox]]", "[[reusability without rapid turnaround and minimal refurbishment does not reduce launch costs as the Space Shuttle proved over 30 years]]"]
|
related_claims: ["[[knowledge embodiment lag means technology is available decades before organizations learn to use it optimally creating a productivity paradox]]", "[[reusability without rapid turnaround and minimal refurbishment does not reduce launch costs as the Space Shuttle proved over 30 years]]"]
|
||||||
|
related: ["manufacturing-rate-does-not-equal-launch-cadence-in-aerospace-operations", "blue-origin-strategic-vision-execution-gap-illustrated-by-project-sunrise-announcement-timing"]
|
||||||
---
|
---
|
||||||
|
|
||||||
# Manufacturing rate does not translate directly to launch cadence because operational integration is a separate bottleneck from hardware production
|
# Manufacturing rate does not translate directly to launch cadence because operational integration is a separate bottleneck from hardware production
|
||||||
|
|
||||||
Blue Origin announced in March 2026 that it is completing one full New Glenn vehicle per month, with CEO Dave Limp stating 12-24 launches possible in 2026. However, NG-3—the third mission and first booster reuse—slipped from late February NET to late March NET without launching by March 27, 2026. This represents a 4-6 week delay on only the third flight. The gap between manufacturing capability (12 vehicles/year) and actual launch execution (2 launches in 14 months: NG-1 in Jan 2025, NG-2 in Nov 2025, NG-3 still pending in late Mar 2026) demonstrates that hardware production rate is not the binding constraint on launch cadence. The CEO identified second stage production as the current bottleneck, but the NG-3 slip suggests operational integration—range availability, payload readiness, ground systems, regulatory clearances, or mission assurance processes—creates additional friction independent of manufacturing throughput. This pattern mirrors the Space Shuttle experience where vehicle availability did not determine flight rate. If manufacturing rate equaled launch rate, Blue Origin would have accumulated significant vehicle inventory by March 2026, yet no evidence of stockpiled flight-ready vehicles has been reported. The delta between stated capability and observed execution is the operational knowledge embodiment gap.
|
Blue Origin announced in March 2026 that it is completing one full New Glenn vehicle per month, with CEO Dave Limp stating 12-24 launches possible in 2026. However, NG-3—the third mission and first booster reuse—slipped from late February NET to late March NET without launching by March 27, 2026. This represents a 4-6 week delay on only the third flight. The gap between manufacturing capability (12 vehicles/year) and actual launch execution (2 launches in 14 months: NG-1 in Jan 2025, NG-2 in Nov 2025, NG-3 still pending in late Mar 2026) demonstrates that hardware production rate is not the binding constraint on launch cadence. The CEO identified second stage production as the current bottleneck, but the NG-3 slip suggests operational integration—range availability, payload readiness, ground systems, regulatory clearances, or mission assurance processes—creates additional friction independent of manufacturing throughput. This pattern mirrors the Space Shuttle experience where vehicle availability did not determine flight rate. If manufacturing rate equaled launch rate, Blue Origin would have accumulated significant vehicle inventory by March 2026, yet no evidence of stockpiled flight-ready vehicles has been reported. The delta between stated capability and observed execution is the operational knowledge embodiment gap.
|
||||||
|
|
||||||
|
|
||||||
|
## Supporting Evidence
|
||||||
|
|
||||||
|
**Source:** SpaceNews, April 2026 — China satellite production analysis
|
||||||
|
|
||||||
|
China's experience provides a second independent validation of the manufacturing-launch decoupling. With 7,360 satellites/year manufacturing capacity built to support 28,000-satellite constellations (Guowang + Qianfan), China explicitly faces launch capacity as 'a significant constraint' per SpaceNews. This confirms the pattern holds across different economic systems—state-directed Chinese manufacturing faces the same launch bottleneck as commercial Western manufacturers.
|
||||||
|
|
|
||||||
52
entities/health/medicare-glp1-bridge-program.md
Normal file
52
entities/health/medicare-glp1-bridge-program.md
Normal file
|
|
@ -0,0 +1,52 @@
|
||||||
|
---
|
||||||
|
type: entity
|
||||||
|
entity_type: research_program
|
||||||
|
name: Medicare GLP-1 Bridge Program
|
||||||
|
domain: health
|
||||||
|
status: active
|
||||||
|
start_date: 2026-07-01
|
||||||
|
end_date: 2026-12-31
|
||||||
|
parent_organization: Centers for Medicare & Medicaid Services (CMS)
|
||||||
|
---
|
||||||
|
|
||||||
|
# Medicare GLP-1 Bridge Program
|
||||||
|
|
||||||
|
A temporary demonstration program providing Medicare Part D coverage for GLP-1 receptor agonists (Wegovy and Zepbound) for obesity treatment from July 1 to December 31, 2026.
|
||||||
|
|
||||||
|
## Program Structure
|
||||||
|
|
||||||
|
**Eligibility:**
|
||||||
|
- BMI ≥35 alone, or ≥27 with clinical criteria
|
||||||
|
- Must be enrolled in Medicare Part D
|
||||||
|
- Estimated ~14 million Medicare beneficiaries had diagnosed overweight/obesity in 2020 (potential eligible pool)
|
||||||
|
|
||||||
|
**Cost-sharing:**
|
||||||
|
- Fixed $50 copayment per prescription
|
||||||
|
- Copay does NOT count toward Part D deductible or $2,100 out-of-pocket cap
|
||||||
|
- Low-Income Subsidy (LIS) cost-sharing subsidies do NOT apply to prescriptions filled under this program
|
||||||
|
|
||||||
|
**Legal Architecture:**
|
||||||
|
- Operates outside standard Part D benefit structures because Medicare is statutorily prohibited from covering weight-loss drugs
|
||||||
|
- Requires CMS demonstration authority, not legislative change
|
||||||
|
- Temporary exception, not durable coverage
|
||||||
|
|
||||||
|
## Structural Issues
|
||||||
|
|
||||||
|
The program's placement outside Part D cost-sharing structures makes Low-Income Subsidy (LIS) protections inapplicable, creating a $50 copay barrier for the lowest-income beneficiaries despite inclusive eligibility criteria. This represents a structural misalignment where coverage expansion and coverage restriction occur simultaneously through different layers of program design.
|
||||||
|
|
||||||
|
## Relationship to Other Programs
|
||||||
|
|
||||||
|
- **BALANCE Model (Medicare Part D):** Longer demonstration launching January 2027
|
||||||
|
- **BALANCE Model (Medicaid):** Begins May 2026
|
||||||
|
- Beneficiaries seeking continued coverage in 2027 may need to switch Part D plans during open enrollment
|
||||||
|
|
||||||
|
## Timeline
|
||||||
|
|
||||||
|
- **2026-04** — Program details announced by CMS
|
||||||
|
- **2026-07-01** — Program begins
|
||||||
|
- **2026-12-31** — Program ends
|
||||||
|
|
||||||
|
## Sources
|
||||||
|
|
||||||
|
- KFF Health Policy analysis (April 2026)
|
||||||
|
- CMS program documents
|
||||||
Loading…
Reference in a new issue